Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Hidetaka Uramoto's publication output changed over time?
ScholarIQpublication output · 2003–2020
Output grew0% over the shown period — from 1 works in 2003 to 1 in 2020.
1
1
1
2
2
1
1
1
1
200320052008201020112012201320142020
What are the most-cited papers on Hidetaka Uramoto?
ScholarIQmost cited works
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
Hiroto Izumi, Takayuki Torigoe, Hiroshi Ishiguchi, Hidetaka Uramoto, Yoichiro Yoshida, Mizuho Tanabe, Tomoko Ise, Tadashi Murakami, Takeshi Yoshida, Minoru Nomoto, Kimitoshi Kohno
S49831067. 2003615 Citations
Recurrence after surgery in patients with NSCLC.
Hidetaka Uramoto, Fumihiro Tanaka
PubMed. 2014558 Citations
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang, Michael Hölzel, Theo Knijnenburg, Andreas Schlicker, Paul Roepman, Ultan McDermott, Mathew J. Garnett, Wipawadee Grernrum, Chong Sun, Anirudh Prahallad, Floris H. Groenendijk, Lorenza Mittempergher, Wouter Nijkamp, Jacques Neefjes, Ramón Salazar, Peter ten Dijke, Hidetaka Uramoto, Fumihiro Tanaka, Roderick L. Beijersbergen, Lodewyk F.A. Wessels, René Bernards
S110447773. 2012434 CitationsOPEN ACCESS
Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort
Seiji Yano, Tadaaki Yamada, Shinji Takeuchi, Keisei Tachibana, Yuko Minami, Yasushi Yatabe, Tetsuya Mitsudomi, Hidenori Tanaka, Tatsuo Kimura, Shinzoh Kudoh, Hiroshi Nokihara, Yuichiro Ohe, Jun Yokota, Hidetaka Uramoto, Kosei Yasumoto, Katsuyuki Kiura, Masahiko Higashiyama, Makoto Oda, Haruhiro Saito, Junji Yoshida, Kazuya Kondoh, Masayuki Noguchi
Journal of Thoracic Oncology. 2011218 CitationsOPEN ACCESS
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
Hiroto Izumi, Mayu Takahashi, Hidetaka Uramoto, Yoshifumi Nakayama, Tsunehiro Oyama, Ke‐Yong Wang, Yasuyuki Sasaguri, Shigeru Nishizawa, Kimitoshi Kohno
S175946340. 2011177 CitationsOPEN ACCESS
Related on ScholarIQ
Kanazawa Medical University
Institution
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
Paper
Recurrence after surgery in patients with NSCLC.
Paper
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Paper
Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort
Paper
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
Paper